ENDRA Life Sciences CCO Renaud Maloberti resigns effective Jan 13, 2023

ENDRA Life Sciences Inc.

Renaud Maloberti resigned as Chief Commercial Officer, effective January 13, 2023.
Resignation not related to any disagreement with company's operations, policies, or practices.
No replacement for the CCO position announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Renaud Maloberti

Chief Commercial Officer

NDRA · ENDRA Life Sciences Inc.

Effective: 2023-01-13
Filed: December 23, 2022, 6:59 PM ET

On December 21, 2022, Renaud Maloberti notified ENDRA Life Sciences Inc. (“ENDRA” or the “Company”) of his resignation as the Company’s Chief Commercial Officer, effective January 13, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Renaud Maloberti resigned as Chief Commercial Officer at ENDRA Life Sciences Inc..

Action: resigned
Role: Chief Commercial Officer

Exact text from the filing

On December 21, 2022, Renaud Maloberti notified ENDRA Life Sciences Inc. (“ENDRA” or the “Company”) of his resignation as the Company’s Chief Commercial Officer, effective January 13, 2023.

View on SEC.gov

ENDRA Life Sciences Inc. filing history →

Source: SEC EDGAR

accession 0001654954-22-016935

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.